Effect of evening primrose oil on clinically diagnosed fibroadenomas

Breast

Volumn 9, Issue 1, 2000, Pages 35-36

  Kollias, J ^a   Macmillan, R D ^a   Sibbering, D M ^a   Burrell, H ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA LINOLENIC ACID; PRIMROSE OIL;

ADULT; ARTICLE; BREAST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBROADENOMA; HUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0034104883     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.1999.0064     Document Type: Article

References (10)

1. Larner J M, Eisenfeld A J, Hochberg R B. Synthesis of estradiol fatty acid esters by human breast tumours: fatty acid composition and comparison to oestrogen and progesterone receptor content. J Steroid Biochem. 23:1985;637-641.
2. Horrobin D F, Manku M S. Pre-menstrual syndrome and pre-menstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism. Prostaglandins Leukot Essent Fatty Acids Reviews. 39:1989;255-261.
3. Williams G T, Potten C, Roberts S, Howell A. The distribution of receptor for estrogen (ER) and progesterone (PR) in the normal breast and its relationship to the menstrual cycle, use of the oral contraceptive pill (OCP) and cell proliferation. Cancer Res (Abs). 62:1990;15.
4. Markopoulos C, Berger U T A, Wilson P, Gazet J-C, Coombes R C. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. BMJ. 296:1998;1349-1351.
5. Nardelli GB, Lamaina V, Siliotti F. Steroid receptors in benign breast disease, gross cystic disease and fibroadenomas. Clinical and Experimental Obstetrics and Gynaecology. 14:1987;10-15.
6. Sainsbury J R C, Nicholson S, Needham G K, Wadehra V, Farndon J R. Natural history of the benign lump. Br J Surg. 75:1988;1080-1082.
7. Dixon J M, Dobie V, Lamb J S, Walsh J S, Chetty U. Assessment of the acceptability of conservative management of fibroadenoma of the breast. Br J Surg. 83:1996;264-265.
8. Sibbering D M, Galea M H, Ellis I O. Safe criteria for conservative management of solid palpable breast lumps in women over 35 years of age. Br J Surg. 81:1994;764.
9. Alle K. Conservative management of fibroadenoma of the breast (reply). Br J Surg. 83:1996;1799.
10. Gateley C A, Maddox P R, Courtney S P, Mansell R E. The effect of danazol on discrete benign breast lumps. J R Coll Surg Edin. 40:1995;371-373.